SLXNSilexion Therapeutics Corpvs its industry peers
A metric-by-metric comparison of Silexion Therapeutics Corp against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLXNEsta | $841267#9 | 0.0x#2 | 19.1x#6 | — | — | 27.9%#5 | — | -27072.7%#5 | — | — | -99.5%#5 | — |
| CELZ | $4M#2 | — | 0.5x#1 | 681.2x#6 | -45.5%#6 | -9.1%#9 | -102380.2%#9 | -69.3%#1 | -66.1%#1 | 3#2 | -79.8%#3 | — |
| LIMNW | $4M#3 | — | 12.5x#5 | — | — | -187.8%#11 | — | -3395.2%#4 | -170.3%#3 | — | -59.9%#2 | — |
| BCAB | — | — | — | — | — | 14.6%#7 | -19768.3%#7 | — | — | — | — | — |
| ESLAW | $3M#4 | — | — | — | — | — | — | — | — | — | — | — |
| CEROW | $3M#5 | — | — | — | — | — | — | — | — | — | — | 4.9%#1 |
| CRIS | $2M#6 | 0.1x#5 | 0.5x#2 | 0.3x#2 | -13.4%#5 | 82.5%#1 | -60.5%#2 | -161.5%#2 | -87.3%#2 | — | — | — |
| CLDI | $2M#8 | 0.0x#4 | 0.6x#3 | 43.1x#5 | — | 10.1%#8 | -44977.8%#8 | -635.4%#3 | — | — | — | — |
| TVGNW | $526132#10 | — | — | — | — | -91.4%#10 | — | — | — | — | — | — |
| VIVS | $2M#7 | — | — | 17.0x#4 | -9.0%#4 | -456.4%#13 | -8768.7%#6 | — | — | — | -93.3%#4 | — |
| SCLXW | $356706#11 | — | — | 0.0x#1 | -46.5%#7 | -413.8%#12 | -1143.7%#3 | — | — | 4#1 | 382.5%#1 | — |
| ABPWW | $116152#12 | 0.0x#3 | — | 0.6x#3 | 50.0%#2 | 60.0%#2 | -4618.6%#4 | — | — | — | — | — |
| SLXNW | $99529#13 | 0.0x#1 | 2.3x#4 | — | — | 27.9%#5 | — | -27072.7%#5 | — | — | — | — |
| ABPO | — | — | — | — | 50.0%#2 | 60.0%#2 | -4618.6%#4 | — | — | — | — | — |
| ADAPY | — | — | — | — | 195.3%#1 | 37.8%#4 | -38.6%#1 | — | — | — | — | — |
| AGMB | $234M#1 | — | — | — | — | — | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-05.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice